Surgery Partners (SGRY) Director Teresa DeLuca Buys 11,250 Shares

What Happened

• Teresa DeLuca, a director of Surgery Partners, acquired 11,250 shares of the company's common stock in an open-market purchase on August 18, 2026, at a weighted-average price of $14.33 per share, for a total cost of about $161,213. This transaction is reported under code P (purchase) and represents a direct buy of shares.

Key Details

• Transaction date and price: Aug 18, 2026 — 11,250 shares at $14.33 (weighted average)
• Total value: approximately $161,213
• Transaction type: Open-market purchase (Code P)
• Shares owned after transaction: The amended Form 4 states the post-transaction beneficial ownership was corrected but the exact total is not provided here; see the filing for the updated ownership figure.
• Footnotes: F1 notes the $14.33 is a weighted-average price and the filer will provide breakdowns on request. F2 explains this is an amendment correcting the originally reported 10,000 shares at $14.35 to the actual 11,250 shares at $14.33; the original Form 4 was filed Aug 19, 2026 and this Form 4/A corrects the figures.
• Timeliness: The original Form 4 was filed Aug 19, 2026 (one day after the trade); the Aug 20, 2026 amendment corrects the reported amounts. Filing appears timely; the amendment fixes reporting errors rather than adding a late report.

Context

• Purchases by directors are often noted by investors as informative because they increase insider exposure to the stock, though they do not prove future performance. This report documents a straightforward open-market purchase (no options exercise, gift, or 10b5-1 plan is indicated). For full details, including the corrected post-transaction ownership number and any additional notes, refer to the Form 4/A filing (Accession 0001638833-26-000081).